Daily Technology
·20/02/2026
Chinese robotics firm Unitree is setting an aggressive pace in the global humanoid robot market, announcing plans to ship up to 20,000 units in 2026. This target represents a significant escalation from the approximately 5,500 units the company shipped in the previous year, signaling a rapid shift from development to mass production.
The company's capabilities were recently showcased at China's annual Spring Festival Gala, an event with a massive international audience. During the broadcast, Unitree's G1 humanoid robots performed complex and fully autonomous martial arts routines. The machines also demonstrated impressive agility, executing trampoline somersaults reaching three meters in height and running at speeds of up to four meters per second (approximately 14 km/h).
These production goals place Unitree and other Chinese manufacturers on a much faster timeline than many of their Western counterparts. For instance, Tesla's Optimus robot is not expected to be released until late 2027. This accelerated schedule is already reflected in market share. In 2025, global humanoid robot shipments reached approximately 13,000 units, with Chinese companies like Unitree and Agibot reportedly accounting for nearly 80% of that total. This trend has prompted financial institutions like Morgan Stanley to double their 2026 sales forecast for China to 28,000 units.
Despite the impressive stage performances, industry figures acknowledge the significant challenges that remain. Unitree's CEO, Wang Xingxing, has identified practical deployment in uncontrolled, real-world environments as the next major hurdle. The key to overcoming this is the development of advanced embodied AI systems, which function as the robot's "brain," allowing for independent navigation and interaction within complex and unpredictable settings. Unitree is actively collaborating with partners to advance this crucial technology.
As Chinese robotics companies like Unitree and LimX Dynamics expand their global presence, the focus is shifting from pure research to industrial-scale deployment. Their strategy of aggressive production and overseas partnerships is positioning them as formidable players in the race to commercialize humanoid robot technology.









